UPDATE 1-Glaxo buys rights to Parkinson's drug from Impax | Reuters
Links shared publicly online about this topic.
- 651total visits
UPDATE 1-Glaxo buys rights to Parkinson's drug from Impax | Reuters
* Impax gets $11.5 mln upfront, up to $175 mln in milestones * Extended release drug IPX066 in Phase III trials (Adds detail, background) LONDON, Dec 16 (Reuters) - GlaxoSmithKline
View full resource at reuters.com
Tags: Parkinson's Disease, Drug, GlaxoSmithKline
Most Recently Shared on December 16, 2010 at 2:22 pm By:
Impax will get $11.5M upfront and up to $175M in milestones from GSK on Parkinson's drug pact. http://reut.rs/eTqKgG
Advertisement
